| Literature DB >> 20851278 |
Yuko Tanibuchi1, Minoru Shimagami, Goro Fukami, Yoshimoto Sekine, Masaomi Iyo, Kenji Hashimoto.
Abstract
Methamphetamine (METH) use is one of the major public health concerns worldwide. Long-term use of METH induces not only dependence but also psychosis which is associated with METH-induced brain damage, including neuroinflammation produced by activated microglia. We report the case of a female patient whose psychotic symptoms in METH use disorder were successfully improved by anti-inflammatory drug minocycline therapy. Although the precise mechanism(s) underlying the efficacy of minocycline in METH use disorder are currently unclear, minocycline appears to be a good candidate for future investigation clinical trials for medication development in METH using populations.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20851278 DOI: 10.1016/j.genhosppsych.2009.12.005
Source DB: PubMed Journal: Gen Hosp Psychiatry ISSN: 0163-8343 Impact factor: 3.238